Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Aspen'S Advisor for Nurse Executives
|
March 1, 1995
Executives share their first-class ideas
M Hawkins, T Curley
Investigational New Drugs
|
July 1, 1989
Phase I clinical trial of doxorubicin and iproplatin combination chemotherapy in patients with breast cancer
E S Casper, T Curley, T B Hakes
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
March 15, 2025
Retinal findings in pediatric idiopathic intracranial hypertension
Michael T Curley, Gena Heidary, Eric D Gaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1993
Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC
H I Scher, N L Geller, T Curley, et al.
Theranostics
|
November 8, 2017
Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities
Colleen T Curley, Natasha D Sheybani, Timothy N Bullock, et al.
Theranostics
|
June 14, 2018
Listening in on the Microbubble Crowd: Advanced Acoustic Monitoring for Improved Control of Blood-Brain Barrier Opening with Focused Ultrasound
Catherine M Gorick, Natasha D Sheybani, Colleen T Curley, et al.
The Journal of Urology
|
March 1, 1992
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer
A D Seidman, H I Scher, D Petrylak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer
W K Kelly, T Curley, C Leibretz, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1992
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors
H I Scher, T Curley, S Yeh, et al.
Seminars in Urology
|
February 1, 1992
Therapeutic alternatives for hormone-refractory prostatic cancer
H I Scher, T Curley, S Yeh, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Aspen'S Advisor for Nurse Executives
|
March 1, 1995
Executives share their first-class ideas
M Hawkins, T Curley
Investigational New Drugs
|
July 1, 1989
Phase I clinical trial of doxorubicin and iproplatin combination chemotherapy in patients with breast cancer
E S Casper, T Curley, T B Hakes
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
|
March 15, 2025
Retinal findings in pediatric idiopathic intracranial hypertension
Michael T Curley, Gena Heidary, Eric D Gaier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1993
Effect of relative cumulative dose-intensity on survival of patients with urothelial cancer treated with M-VAC
H I Scher, N L Geller, T Curley, et al.
Theranostics
|
November 8, 2017
Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities
Colleen T Curley, Natasha D Sheybani, Timothy N Bullock, et al.
Theranostics
|
June 14, 2018
Listening in on the Microbubble Crowd: Advanced Acoustic Monitoring for Improved Control of Blood-Brain Barrier Opening with Focused Ultrasound
Catherine M Gorick, Natasha D Sheybani, Colleen T Curley, et al.
The Journal of Urology
|
March 1, 1992
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer
A D Seidman, H I Scher, D Petrylak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer
W K Kelly, T Curley, C Leibretz, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1992
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors
H I Scher, T Curley, S Yeh, et al.
Seminars in Urology
|
February 1, 1992
Therapeutic alternatives for hormone-refractory prostatic cancer
H I Scher, T Curley, S Yeh, et al.
Page
of 3